ALEC

Alector, Inc.

Sales chart range
Log in to watch ALEC
Latest sale
$25k
Sep 4 · No plan
Form 4 sales
143
On record
Form 144 notices
17
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
3
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    Mar 10 2026

    Sold 1,000 shares at $2.65 ($3k)

    Wong-Sarad Grace, Principal Accounting Officer

    10b5-1 planSold 0.9% of holdings ($285k position)106,465 shares left0.2x usual sizeFiling

  2. 2 Form 4 saleRoutine
    Apr 16 +37 days

    Sold 1,820 shares at $2.65 ($5k)

    Wong-Sarad Grace, Principal Accounting Officer

    10b5-1 planSold 1.7% of holdings ($282k position)104,645 shares left0.4x usual sizeFiling

  3. 3 Form 4 saleNo plan
    Jun 2 +47 days

    Sold 19,360 shares at $1.97 ($38k)

    Berkley Neil Lindsay, CFO & Chief Business Officer

    No 10b5-1 planSold 4.8% of holdings ($787k position)379,900 shares left0.7x usual sizeFiling

  4. 4 Form 4 saleNo plan
    Jun 2 same day

    Sold 87,216 shares at $1.97 ($172k)

    Rosenthal Arnon, Chief Executive Officer

    No 10b5-1 planSold 3.6% of holdings ($4.8M position)2.4M shares left1.7x usual sizeFiling

  5. 5 Form 4 saleNo plan
    Jun 3 +1 day

    Sold 9,184 shares at $1.94 ($18k)

    Wong-Sarad Grace, Principal Accounting Officer

    No 10b5-1 planSold 8.8% of holdings ($203k position)95,461 shares left2.1x usual sizeFiling

  6. 6 Form 4 saleNo plan
    Sep 3 +92 days

    Sold 29,251 shares at $2.66 ($78k)

    Berkley Neil Lindsay, CFO & Chief Business Officer

    No 10b5-1 planSold 7.7% of holdings ($1M position)350,649 shares left1.2x usual sizeFiling

  7. 7 Form 4 saleNo plan
    Sep 3 same day

    Sold 72,606 shares at $2.66 ($193k)

    Rosenthal Arnon, Chief Executive Officer

    No 10b5-1 planSold 3.1% of holdings ($6.3M position)2.3M shares left1.4x usual sizeFiling

  8. 8 Form 4 saleNo plan
    Sep 4 +1 day

    Sold 9,446 shares at $2.61 ($25k)

    Wong-Sarad Grace, Principal Accounting Officer

    No 10b5-1 planSold 8.2% of holdings ($302k position)106,015 shares left2x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (160)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for ALEC
Source
Sep 4, 2026Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale9,446$25k8.2%No planSEC
Sep 3, 2026Rosenthal ArnonChief Executive OfficerForm 4 sale72,606$193k3.1%No planSEC
Sep 3, 2026Berkley Neil LindsayCFO & Chief Business OfficerForm 4 sale29,251$78k7.7%No planSEC
Jun 3, 2026Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale9,184$18k8.8%No planSEC
Jun 2, 2026Rosenthal ArnonChief Executive OfficerForm 4 sale87,216$172k3.6%No planSEC
Jun 2, 2026Berkley Neil LindsayCFO & Chief Business OfficerForm 4 sale19,360$38k4.8%No planSEC
Apr 16, 2026Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale1,820$5k1.7%RoutineSEC
Mar 10, 2026Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale1,000$3k0.9%RoutineSEC
Mar 3, 2026Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale3,367$7k3.0%RoutineSEC
Mar 2, 2026Berkley Neil LindsayCFO & Chief Business OfficerForm 4 sale29,649$63k7.9%No planSEC
Mar 2, 2026Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale8,071$17k6.8%No planSEC
Mar 2, 2026Rosenthal ArnonChief Executive OfficerForm 4 sale81,864$174k3.4%No planSEC
Feb 26, 2026Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale4,079$10k3.3%RoutineSEC
Dec 5, 2025Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale4,753$6k3.7%No planSEC
Dec 3, 2025Berkley Neil LindsayChief Bus Ofcr & Interim CFOForm 4 sale37,261$42k9.1%No planSEC
Dec 3, 2025Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale8,056$9k5.9%No planSEC
Dec 3, 2025Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale41,687$47k7.7%No planSEC
Dec 3, 2025Rosenthal ArnonChief Executive OfficerForm 4 sale104,347$117k4.1%UnusualSEC
Sep 2, 2025Wong-Sarad GracePrincipal Accounting OfficerForm 4 sale5,910$15k5.4%No planSEC
Sep 2, 2025Berkley Neil LindsayPrincipal Financial OfficerForm 4 sale15,842$40k4.4%No planSEC
Sep 2, 2025Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale23,638$59k4.2%No planSEC
Sep 2, 2025Rosenthal ArnonChief Executive OfficerForm 4 sale51,562$129k2.1%No planSEC
Aug 26, 2025Hammond PaulaDirectorForm 4 sale14,000$33k15.7%RoutineSEC
Jun 20, 2025Yaffe KristineDirectorForm 4 sale1,000$1k1.0%RoutineSEC
Jun 2, 2025Grasso MarcChief Financial OfficerForm 4 sale16,488$22k5.3%No planSEC
Jun 2, 2025Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale23,890$32k4.5%No planSEC
Jun 2, 2025Rosenthal ArnonChief Executive OfficerForm 4 sale52,087$70k2.1%No planSEC
Mar 3, 2025Grasso MarcChief Financial OfficerForm 4 sale18,091$27k5.5%UnusualSEC
Mar 3, 2025Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale29,073$43k5.1%No planSEC
Mar 3, 2025Rosenthal ArnonChief Executive OfficerForm 4 sale40,330$59k1.6%No planSEC
Mar 3, 2025Romano GaryChief Medical OfficerForm 4 sale16,306$24k4.7%No planSEC
Dec 2, 2024Grasso MarcChief Financial OfficerForm 4 sale16,489$42k4.7%No planSEC
Dec 2, 2024Rosenthal ArnonChief Executive OfficerForm 4 sale52,172$131k2.0%No planSEC
Dec 2, 2024Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale26,500$67k4.5%No planSEC
Dec 2, 2024Romano GaryChief Medical OfficerForm 4 sale14,892$38k4.1%No planSEC
Nov 29, 2024Romano GaryOfficerForm 144 notice14,306$37kNoticeSEC
Nov 29, 2024Kenkare-Mitra SaraOfficerForm 144 notice25,465$66kNoticeSEC
Nov 29, 2024Grasso MarcOfficerForm 144 notice15,842$41kNoticeSEC
Nov 29, 2024Rosenthal ArnonOfficer, DirectorForm 144 notice50,142$130kNoticeSEC
Sep 3, 2024Grasso MarcChief Financial OfficerForm 4 sale7,297$36k5.3%No planSEC
Sep 3, 2024Rosenthal ArnonChief Executive OfficerForm 4 sale26,499$129k1.3%No planSEC
Sep 3, 2024Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale13,926$68k4.6%No planSEC
Sep 3, 2024Romano GaryChief Medical OfficerForm 4 sale8,478$41k4.5%No planSEC
Aug 22, 2024Scheller Richard HDirectorForm 4 sale44,250$228k55.8%UnusualSEC
Aug 12, 2024Hammond PaulaDirectorForm 4 sale10,500$53k14.8%RoutineSEC
Aug 12, 2024Yaffe KristineDirectorForm 4 sale5,000$25k6.9%RoutineSEC
Jun 3, 2024Rosenthal ArnonChief Executive OfficerForm 4 sale25,135$121k1.3%No planSEC
Jun 3, 2024Romano GaryChief Medical OfficerForm 4 sale8,040$39k4.1%No planSEC
Jun 3, 2024Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale13,206$63k4.1%No planSEC
Jun 3, 2024Grasso MarcChief Financial OfficerForm 4 sale6,920$33k4.8%UnusualSEC
Mar 4, 2024Romano GaryChief Medical OfficerForm 4 sale6,001$42k3.0%No planSEC
Mar 4, 2024Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale10,169$70k3.1%No planSEC
Mar 4, 2024Grasso MarcChief Financial OfficerForm 4 sale5,716$40k3.8%UnusualSEC
Mar 4, 2024Rosenthal ArnonChief Executive OfficerForm 4 sale18,837$130k0.9%UnusualSEC
Dec 4, 2023Rosenthal ArnonChief Executive OfficerForm 4 sale23,831$133k1.2%UnusualSEC
Dec 4, 2023Romano GaryChief Medical OfficerForm 4 sale5,035$28k2.4%No planSEC
Dec 4, 2023Grasso MarcChief Financial OfficerForm 4 sale4,574$25k2.9%UnusualSEC
Dec 4, 2023Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale12,519$70k3.7%No planSEC
Dec 1, 2023Romano GaryOfficerForm 144 notice5,035$28kNoticeSEC
Dec 1, 2023Grasso MarcOfficerForm 144 notice4,574$25kNoticeSEC
Dec 1, 2023Kenkare-Mitra SaraOfficerForm 144 notice12,519$70kNoticeSEC
Dec 1, 2023Rosenthal ArnonOfficer, DirectorForm 144 notice23,831$133kNoticeSEC
Sep 11, 2023Polaris Venture Management Co. VI, L.L.C.10% ownerForm 4 sale500,000$3M4.4%No planSEC
Sep 11, 2023Mcguire TerranceDirector, 10% ownerForm 4 sale500,000$3M4.4%No planSEC
Sep 11, 2023Polaris Venture Partners VI (AIV-B), L.P.Director, 10% StockholderForm 144 notice93,214$559kNoticeSEC
Sep 11, 2023Polaris Venture Partners VI (AIV), L.P.Director, 10% StockholderForm 144 notice379,180$2.3MNoticeSEC
Sep 11, 2023Polaris Venture Partners Founders' Fund VI, L.P.Director, 10% StockholderForm 144 notice27,606$166kNoticeSEC
Sep 5, 2023Rosenthal ArnonChief Executive OfficerForm 4 sale5,647$29k0.3%No planSEC
Sep 5, 2023Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale6,214$32k3.4%No planSEC
Sep 5, 2023Romano GaryChief Medical OfficerForm 4 sale2,771$14k2.7%No planSEC
Sep 5, 2023Grasso MarcChief Financial OfficerForm 4 sale1,114$6k3.3%No planSEC
Sep 1, 2023Rosenthal ArnonOfficer, DirectorForm 144 notice5,233$29kNoticeSEC
Sep 1, 2023Kenkare-Mitra SaraOfficerForm 144 notice5,759$32kNoticeSEC
Sep 1, 2023Romano GaryOfficerForm 144 notice2,567$14kNoticeSEC
Jun 2, 2023Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale4,092$28k2.2%No planSEC
Jun 2, 2023Grasso MarcChief Financial OfficerForm 4 sale1,050$7k3.1%No planSEC
Jun 2, 2023Romano GaryChief Medical OfficerForm 4 sale2,617$18k2.5%No planSEC
Jun 2, 2023Rosenthal ArnonChief Executive OfficerForm 4 sale5,255$36k0.3%No planSEC
Jun 1, 2023Kenkare-Mitra SaraOfficerForm 144 notice3,956$27kNoticeSEC
Jun 1, 2023Romano GaryOfficerForm 144 notice2,567$18kNoticeSEC
Jun 1, 2023Rosenthal ArnonOfficer, DirectorForm 144 notice5,102$35kNoticeSEC
Mar 17, 2023Rosenthal ArnonChief Executive OfficerForm 4 sale15,186$94k0.9%No planSEC
Mar 2, 2023Romano GaryChief Medical OfficerForm 4 sale5,383$46k4.9%Plan not statedSEC
Mar 2, 2023Kenkare-Mitra SaraPresident and Head of R&DForm 4 sale10,124$84k5.1%Plan not statedSEC
Mar 2, 2023Grasso MarcChief Financial OfficerForm 4 sale1,291$11k3.6%Plan not statedSEC
Mar 2, 2023Rosenthal ArnonChief Executive OfficerForm 4 sale5,849$49k0.4%Plan not statedSEC
Sep 2, 2022Romano GaryChief Medical OfficerForm 4 sale2,177$23k2.4%Plan not statedSEC
Sep 2, 2022King RobertChief Development OfficerForm 4 sale176$2k0.0%Plan not statedSEC
Jun 2, 2022King RobertChief Development OfficerForm 4 sale177$2k0.0%Plan not statedSEC
Mar 1, 2022King RobertChief Development OfficerForm 4 sale287$4k0.1%Plan not statedSEC
Dec 13, 2021Suliman ShehnaazPresident and COOForm 4 sale150,000$3.2M59.4%UnusualSEC
Dec 9, 2021Suliman ShehnaazPresident and COOForm 4 sale150,000$3.4M59.4%UnusualSEC
Dec 1, 2021King RobertChief Development OfficerForm 4 sale250$5k0.0%Plan not statedSEC
Nov 11, 2021Rosenthal ArnonChief Executive OfficerForm 4 sale110,000$2.8M5.3%Plan not statedSEC
Nov 9, 2021Rosenthal ArnonChief Executive OfficerForm 4 sale200,000$5M23.5%Plan not statedSEC
Nov 5, 2021Rosenthal ArnonChief Executive OfficerForm 4 sale200,000$5M22.7%Plan not statedSEC
Sep 23, 2021Rosenthal ArnonChief Executive OfficerForm 4 sale109,625$2.8M4.5%Plan not statedSEC
Sep 21, 2021Rosenthal ArnonChief Executive OfficerForm 4 sale200,000$5.2M7.7%Plan not statedSEC
Aug 9, 2021Paul RobertChief Medical OfficerForm 4 sale22,950$624k8.9%Plan not statedSEC
Aug 5, 2021Scheller Richard HDirectorForm 4 sale66,241$1.9M100.0%UnusualSEC
Jul 7, 2021Paul RobertChief Medical OfficerForm 4 sale59,749$2.3M20.3%UnusualSEC
Jul 6, 2021Yu CalvinVice President, FinanceForm 4 sale114,174$3.7M59.8%UnusualSEC
Jul 2, 2021King RobertChief Development OfficerForm 4 sale60,000$1.9M10.3%UnusualSEC
Jul 2, 2021Paul RobertChief Medical OfficerForm 4 sale56,726$1.5M19.5%UnusualSEC
Jun 16, 2021Paul RobertChief Medical OfficerForm 4 sale34,600$764k11.2%UnusualSEC
Jun 8, 2021Paul RobertChief Medical OfficerForm 4 sale19,175$368k6.5%Plan not statedSEC
Jun 2, 2021Yu CalvinVice President, FinanceForm 4 sale1,844$33k1.4%Plan not statedSEC
May 21, 2021Paul RobertChief Medical OfficerForm 4 sale14,975$272k5.2%Plan not statedSEC
May 18, 2021Paul RobertChief Medical OfficerForm 4 sale4,200$76k1.5%Plan not statedSEC
Apr 7, 2021Paul RobertChief Medical OfficerForm 4 sale22,300$428k9.4%Plan not statedSEC
Mar 23, 2021Paul RobertChief Medical OfficerForm 4 sale43,800$996k17.0%UnusualSEC
Mar 9, 2021Paul RobertChief Medical OfficerForm 4 sale19,175$347k8.2%Plan not statedSEC
Feb 9, 2021Paul RobertChief Medical OfficerForm 4 sale19,175$399k8.2%Plan not statedSEC
Jan 26, 2021Name not statedChief Medical OfficerForm 4 sale57,308$1M21.1%UnusualSEC
Jan 20, 2021Paul RobertChief Medical OfficerForm 4 sale38,567$698k15.3%UnusualSEC
Jul 15, 2020Paul RobertChief Medical OfficerForm 4 sale10,000$230k4.5%Plan not statedSEC
Jun 23, 2020Mcguire TerranceDirector, 10% ownerForm 4 sale4,377$138k0.0%Plan not statedSEC
Jun 23, 2020Polaris Venture Partners VI (AIV), L.P.10% ownerForm 4 sale4,377$138k0.0%Plan not statedSEC
Jun 15, 2020Paul RobertChief Medical OfficerForm 4 sale10,000$296k4.3%Plan not statedSEC
Jun 3, 2020Yu CalvinVice President, FinanceForm 4 sale1,343$42k1.2%Plan not statedSEC
May 15, 2020Paul RobertChief Medical OfficerForm 4 sale10,000$270k4.1%Plan not statedSEC
May 15, 2020King RobertChief Development OfficerForm 4 sale15,000$405k3.0%Plan not statedSEC
Apr 16, 2020Orbimed Advisors LLC10% ownerForm 4 sale85,414$2M4.3%Plan not statedSEC
Apr 15, 2020Paul RobertChief Medical OfficerForm 4 sale10,000$223k3.9%Plan not statedSEC
Apr 9, 2020Orbimed Advisors LLC10% ownerForm 4 sale379,885$9M16.5%Plan not statedSEC
Mar 31, 2020Orbimed Advisors LLC10% ownerForm 4 sale250,000$6.1M11.0%Plan not statedSEC
Mar 25, 2020Orbimed Advisors LLC10% ownerForm 4 sale138,653$3.4M6.2%Plan not statedSEC
Mar 13, 2020Paul RobertChief Medical OfficerForm 4 sale10,000$229k3.8%Plan not statedSEC
Mar 2, 2020Orbimed Advisors LLC10% ownerForm 4 sale1.9M$48.7M100.0%UnusualSEC
Feb 14, 2020King RobertChief Development OfficerForm 4 sale15,000$443k3.0%Plan not statedSEC
Feb 14, 2020Paul RobertChief Medical OfficerForm 4 sale10,000$295k3.7%Plan not statedSEC
Feb 7, 2020Oney SabahChief Business OfficerForm 4 sale19,900$697k3.4%Plan not statedSEC
Feb 7, 2020Yu CalvinVice President, FinanceForm 4 sale26,654$933k19.4%Plan not statedSEC
Feb 6, 2020Oney SabahChief Business OfficerForm 4 sale16,767$504k2.7%Plan not statedSEC
Feb 5, 2020Paul RobertChief Medical OfficerForm 4 sale10,000$321k3.5%Plan not statedSEC
Feb 4, 2020Scheller Richard HDirectorForm 4 sale10,000$297k50.0%UnusualSEC
Feb 4, 2020Yu CalvinVice President, FinanceForm 4 sale63,541$1.9M33.6%UnusualSEC
Jan 30, 2020Paul RobertChief Medical OfficerForm 4 sale8,000$224k2.8%Plan not statedSEC
Jan 27, 2020Oney SabahChief Business OfficerForm 4 sale16,667$418k2.7%UnusualSEC
Jan 23, 2020Paul RobertChief Medical OfficerForm 4 sale6,000$146k2.1%Plan not statedSEC
Jan 22, 2020King RobertChief Development OfficerForm 4 sale15,000$330k2.9%Plan not statedSEC
Jan 15, 2020Paul RobertChief Medical OfficerForm 4 sale10,000$187k3.5%Plan not statedSEC
Jan 9, 2020Orbimed Capital LLC10% ownerForm 4 sale379,997$7.4M90.7%UnusualSEC
Dec 26, 2019Orbimed Advisors LLC10% ownerForm 4 sale519,385$10.2M92.8%UnusualSEC
Dec 17, 2019Orbimed Advisors LLC10% ownerForm 4 sale954,100$17.7M90.7%UnusualSEC
Dec 13, 2019Paul RobertChief Medical OfficerForm 4 sale10,000$200k3.4%Plan not statedSEC
Dec 12, 2019Oney SabahChief Business OfficerForm 4 sale6,810$137k1.1%UnusualSEC
Dec 10, 2019Oney SabahChief Business OfficerForm 4 sale500$10k0.1%Plan not statedSEC
Dec 9, 2019Oney SabahChief Business OfficerForm 4 sale8,956$179k1.5%Plan not statedSEC
Dec 3, 2019Yu CalvinVice President, FinanceForm 4 sale1,315$24k0.7%Plan not statedSEC
Nov 15, 2019King RobertChief Development OfficerForm 4 sale7,500$119k1.4%Plan not statedSEC
Nov 15, 2019Paul RobertChief Medical OfficerForm 4 sale10,000$159k3.3%Plan not statedSEC
Oct 15, 2019Paul RobertChief Medical OfficerForm 4 sale10,000$147k3.2%Plan not statedSEC
Sep 20, 2019Oney SabahChief Business OfficerForm 4 sale400$8k0.1%Plan not statedSEC
Sep 20, 2019Paul RobertChief Medical OfficerForm 4 sale4,000$80k1.3%Plan not statedSEC
Sep 16, 2019Paul RobertChief Medical OfficerForm 4 sale10,000$191k3.1%Plan not statedSEC
Aug 20, 2019Paul RobertChief Medical OfficerForm 4 sale2,000$32k0.6%Plan not statedSEC
Aug 19, 2019King RobertChief Development OfficerForm 4 sale7,500$113k1.4%Plan not statedSEC
Aug 15, 2019Paul RobertChief Medical OfficerForm 4 sale10,000$142k3.0%Plan not statedSEC
Aug 7, 2019OrbiMed Capital GP IV LLC10% ownerForm 4 sale650,000$11.6M18.0%Plan not statedSEC